Record Display for the EPA National Library Catalog

RECORD NUMBER: 1 OF 1

Main Title Environmental Technology Verification (ETV) Testing of Three Immunoassay Tests Kits for Anthrax, Botulinum Toxin and Ricin: BioVeris; PHARMALEADS; and QTL Biosystems LLC.
Author Schrock, M. ; James, R. ; Dindal, A. ; Willenberg, Z. ; Riggs, K. ;
CORP Author Battelle Columbus Div., OH.;Environmental Protection Agency, Research Triangle Park, N.C.
Publisher Sep 2006
Year Published 2006
Report Number EPA/600/R-06/147; NERL-RTP-HEASD-06-158;
Stock Number PB2007-105370
Additional Subjects Anthrax ; Ricin ; Environmental monitoring ; Performance evaluation ; Immunoassays ; Testing ; Quality assurance ; Quality control ; Statistical methods ; Test results ; Test design ; Test procedures ; Monitoring ; Immunoassay test kits ; Botulinum toxin ; M-SERIES M1M analyzer ; EzyBot A test kit ; EzyBot B test kit ; QTL Biosensor ; Test kits
Holdings
Library Call Number Additional Info Location Last
Modified
Checkout
Status
NTIS  PB2007-105370 Some EPA libraries have a fiche copy filed under the call number shown. 07/26/2022
Collation 130p
Abstract
The U.S. Environmental Protection Agency (EPA) supports the Environmental Technology Verification (ETV) Program to facilitate the deployment of innovative environmental technologies through performance verification and dissemination of information. The goal of the ETV Program is to further environmental protection by accelerating the acceptance and use of improved and cost-effective technologies. ETV seeks to achieve this goal by providing high quality, peer-reviewed data on technology performance to those involved in the design, distribution, financing, permitting, purchase, and use of environmental technologies. ETV works in partnership with recognized testing organizations; with stakeholder groups consisting of buyers, vendor organizations, and permitters; and with the full participation of individual technology developers. The program evaluates the performance of innovative technologies by developing test plans that are responsive to the needs of stakeholders, conducting field or laboratory tests (as appropriate), collecting and analyzing data, and preparing peer-reviewed reports. All evaluations are conducted in accordance with rigorous quality assurance (QA) protocols to ensure that data of known and adequate quality are generated and that the results are defensible. The EPA's National Exposure Research Laboratory and its verification organization partner, Battelle, operate the Advanced Monitoring Systems (AMS) Center under ETV. The AMS Center recently evaluated the performance of the BioVeris BioVerify(TM) Botulinum Toxin A and Ricin Test Kits using the BioVeris M-SERIES(Registered Trademark) M1M analyzer. Immunoassay test kits were identified as a priority technology category for verification through the AMS Center stakeholder process.